List of Tables
Table 1. Global Intra-abdominal Infection Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Chloramphenicol
Table 3. Key Players of Beta Lactums
Table 4. Key Players of Quinolones
Table 5. Key Players of Aminoglycosides
Table 6. Key Players of Others
Table 7. Global Intra-abdominal Infection Treatment Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Intra-abdominal Infection Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Intra-abdominal Infection Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Intra-abdominal Infection Treatment Drugs Market Share by Region (2020-2025)
Table 11. Global Intra-abdominal Infection Treatment Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Intra-abdominal Infection Treatment Drugs Market Share by Region (2026-2031)
Table 13. Intra-abdominal Infection Treatment Drugs Market Trends
Table 14. Intra-abdominal Infection Treatment Drugs Market Drivers
Table 15. Intra-abdominal Infection Treatment Drugs Market Challenges
Table 16. Intra-abdominal Infection Treatment Drugs Market Restraints
Table 17. Global Intra-abdominal Infection Treatment Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Intra-abdominal Infection Treatment Drugs Market Share by Players (2020-2025)
Table 19. Global Top Intra-abdominal Infection Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intra-abdominal Infection Treatment Drugs as of 2024)
Table 20. Ranking of Global Top Intra-abdominal Infection Treatment Drugs Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Intra-abdominal Infection Treatment Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Intra-abdominal Infection Treatment Drugs, Headquarters and Area Served
Table 23. Global Key Players of Intra-abdominal Infection Treatment Drugs, Product and Application
Table 24. Global Key Players of Intra-abdominal Infection Treatment Drugs, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Intra-abdominal Infection Treatment Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Intra-abdominal Infection Treatment Drugs Revenue Market Share by Type (2020-2025)
Table 28. Global Intra-abdominal Infection Treatment Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Intra-abdominal Infection Treatment Drugs Revenue Market Share by Type (2026-2031)
Table 30. Global Intra-abdominal Infection Treatment Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Intra-abdominal Infection Treatment Drugs Revenue Market Share by Application (2020-2025)
Table 32. Global Intra-abdominal Infection Treatment Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Intra-abdominal Infection Treatment Drugs Revenue Market Share by Application (2026-2031)
Table 34. North America Intra-abdominal Infection Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Intra-abdominal Infection Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Intra-abdominal Infection Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Intra-abdominal Infection Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Intra-abdominal Infection Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Intra-abdominal Infection Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Intra-abdominal Infection Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Intra-abdominal Infection Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Intra-abdominal Infection Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 49. AstraZeneca Company Details
Table 50. AstraZeneca Business Overview
Table 51. AstraZeneca Intra-abdominal Infection Treatment Drugs Product
Table 52. AstraZeneca Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 53. AstraZeneca Recent Development
Table 54. Merck Company Details
Table 55. Merck Business Overview
Table 56. Merck Intra-abdominal Infection Treatment Drugs Product
Table 57. Merck Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 58. Merck Recent Development
Table 59. Pfizer Company Details
Table 60. Pfizer Business Overview
Table 61. Pfizer Intra-abdominal Infection Treatment Drugs Product
Table 62. Pfizer Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 63. Pfizer Recent Development
Table 64. AtoxBio Company Details
Table 65. AtoxBio Business Overview
Table 66. AtoxBio Intra-abdominal Infection Treatment Drugs Product
Table 67. AtoxBio Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 68. AtoxBio Recent Development
Table 69. Dainippon Sumitomo Pharma Company Details
Table 70. Dainippon Sumitomo Pharma Business Overview
Table 71. Dainippon Sumitomo Pharma Intra-abdominal Infection Treatment Drugs Product
Table 72. Dainippon Sumitomo Pharma Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 73. Dainippon Sumitomo Pharma Recent Development
Table 74. Bayer Company Details
Table 75. Bayer Business Overview
Table 76. Bayer Intra-abdominal Infection Treatment Drugs Product
Table 77. Bayer Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 78. Bayer Recent Development
Table 79. Bristol-Myers Squibb Company Details
Table 80. Bristol-Myers Squibb Business Overview
Table 81. Bristol-Myers Squibb Intra-abdominal Infection Treatment Drugs Product
Table 82. Bristol-Myers Squibb Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 83. Bristol-Myers Squibb Recent Development
Table 84. Mylan Pharmaceuticals Inc. Company Details
Table 85. Mylan Pharmaceuticals Inc. Business Overview
Table 86. Mylan Pharmaceuticals Inc. Intra-abdominal Infection Treatment Drugs Product
Table 87. Mylan Pharmaceuticals Inc. Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 88. Mylan Pharmaceuticals Inc. Recent Development
Table 89. Sun Pharmaceutical Industries, Inc. Company Details
Table 90. Sun Pharmaceutical Industries, Inc. Business Overview
Table 91. Sun Pharmaceutical Industries, Inc. Intra-abdominal Infection Treatment Drugs Product
Table 92. Sun Pharmaceutical Industries, Inc. Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 93. Sun Pharmaceutical Industries, Inc. Recent Development
Table 94. Teva Pharmaceutical Industries Company Details
Table 95. Teva Pharmaceutical Industries Business Overview
Table 96. Teva Pharmaceutical Industries Intra-abdominal Infection Treatment Drugs Product
Table 97. Teva Pharmaceutical Industries Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 98. Teva Pharmaceutical Industries Recent Development
Table 99. Dr. Reddy’s Laboratories Company Details
Table 100. Dr. Reddy’s Laboratories Business Overview
Table 101. Dr. Reddy’s Laboratories Intra-abdominal Infection Treatment Drugs Product
Table 102. Dr. Reddy’s Laboratories Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 103. Dr. Reddy’s Laboratories Recent Development
Table 104. Roche Holding AG Company Details
Table 105. Roche Holding AG Business Overview
Table 106. Roche Holding AG Intra-abdominal Infection Treatment Drugs Product
Table 107. Roche Holding AG Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 108. Roche Holding AG Recent Development
Table 109. GlaxoSmithKline Company Details
Table 110. GlaxoSmithKline Business Overview
Table 111. GlaxoSmithKline Intra-abdominal Infection Treatment Drugs Product
Table 112. GlaxoSmithKline Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 113. GlaxoSmithKline Recent Development
Table 114. Sanofi Company Details
Table 115. Sanofi Business Overview
Table 116. Sanofi Intra-abdominal Infection Treatment Drugs Product
Table 117. Sanofi Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 118. Sanofi Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
Table 122. Authors List of This Report
List of Figures
Figure 1. Intra-abdominal Infection Treatment Drugs Picture
Figure 2. Global Intra-abdominal Infection Treatment Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Intra-abdominal Infection Treatment Drugs Market Share by Type: 2024 VS 2031
Figure 4. Chloramphenicol Features
Figure 5. Beta Lactums Features
Figure 6. Quinolones Features
Figure 7. Aminoglycosides Features
Figure 8. Others Features
Figure 9. Global Intra-abdominal Infection Treatment Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Intra-abdominal Infection Treatment Drugs Market Share by Application: 2024 VS 2031
Figure 11. Intra-abdominal Abscess Case Studies
Figure 12. Appendicitis Case Studies
Figure 13. Diverticulitis Case Studies
Figure 14. Diarrhea Case Studies
Figure 15. Food Poisoning Case Studies
Figure 16. Infection by Helicobacter Pylori Case Studies
Figure 17. Intra-abdominal Infection Treatment Drugs Report Years Considered
Figure 18. Global Intra-abdominal Infection Treatment Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Intra-abdominal Infection Treatment Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Intra-abdominal Infection Treatment Drugs Market Share by Region: 2024 VS 2031
Figure 21. Global Intra-abdominal Infection Treatment Drugs Market Share by Players in 2024
Figure 22. Global Top Intra-abdominal Infection Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intra-abdominal Infection Treatment Drugs as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Intra-abdominal Infection Treatment Drugs Revenue in 2024
Figure 24. North America Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Intra-abdominal Infection Treatment Drugs Market Share by Country (2020-2031)
Figure 26. United States Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Intra-abdominal Infection Treatment Drugs Market Share by Country (2020-2031)
Figure 30. Germany Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Share by Region (2020-2031)
Figure 38. China Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Intra-abdominal Infection Treatment Drugs Market Share by Country (2020-2031)
Figure 46. Mexico Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Share by Country (2020-2031)
Figure 50. Turkey Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. AstraZeneca Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 54. Merck Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 55. Pfizer Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 56. AtoxBio Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 57. Dainippon Sumitomo Pharma Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 58. Bayer Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 60. Mylan Pharmaceuticals Inc. Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 61. Sun Pharmaceutical Industries, Inc. Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 62. Teva Pharmaceutical Industries Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 63. Dr. Reddy’s Laboratories Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 64. Roche Holding AG Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 65. GlaxoSmithKline Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 66. Sanofi Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
